Metabolic control and incidence of hypoglycaemia, hospitalisation and complications among Saudi patients with type 2 diabetes initiating second-line therapy: an analysis of the Saudi Arabia data from the DISCOVER Observational Study programme.

ABSTRACT:

Objectives

The aim of the global DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings (DISCOVER) Study was to provide a comprehensive real world assessment of the treatment pattern changes for patients with type 2 diabetes. The aim of this analysis was to assess the metabolic control and the annual incidence of hypoglycaemia, hospitalisation and complications among Saudi patients with type 2 diabetes initiating second-line therapy.

Design

This study is part of the observational, longitudinal, prospective multinational DISCOVER Study.

Setting

Governmental and private health sectors from different regions within Saudi Arabia.

Participants

The study recruited 519 patients with type 2 diabetes aged ≥18 years who were switching to second-line ther

SUBMITTER: Al Rubeaan K 

PROVIDER: S-EPMC10471852 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature